Clinical Trial

Laser Therapy for Perioral Dermatitis

Study Description

Laser Therapy for Perioral Dermatitis

Perioral dermatitis is an inflammation of the skin around the mouth. The cause of perioral dermatitis is unknown. Current treatment methods include oral antibiotics and topical calcenurin inhibitors, both of which produce side effects and have been relatively ineffective in the treatment of perioral dermatitis. The investigators hope to assess the efficacy of laser therapy in treatment of perioral dermatitis by using laser therapy on one half of the patients face and having patients apply topical medication (clindamycin) to their face for 8 weeks. The side of their face that receives laser therapy will be randomized. The investigators will assess the efficacy of laser therapy by counting the number of lesions that patients have before and after laser therapy, comparing photos of patient's perioral dermatitis before and after treatment, and having patient's rate their satisfaction of the treatment.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Device - Pulse laser dye therapy (Device name: Candela Family of Pulsed Dye Laser Systems. 501k Number: K050673.)

The face will be split and randomized, one half will receive pulsed laser dye therapy.

Drug - Clindamycin

The entire face (both halves) will receive clindamycin.

Additional Information

Official Study Title

Laser Therapy for Perioral Dermatitis

Clinical Trial ID

NCT03779295

ParticipAid ID

bqxM3a